ARCHIVES

NTP Panel Completed To Write New Testing, Evolution Guidelines

This article is from The Cancer Letter archive.

Vol. 09 No. 16 | April 22, 1983

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992